Tag: CBD

  • http://thehealthequity.com/wp-content/uploads/2018/06/dea-cbd-696x366.jpg

    Federal Court Proves Gov’t Loyalty to Big Pharma, Rules CBD Has No Medical Value

    Washington, D.C. – The United States hemp industry was dealt a major blow on Monday after the federal U.S.  9th Circuit Court of Appeals upheld a decision by the Drug Enforcement Agency to list cannabidiol, commonly referred to as CBD, which is a non-psychoactive cannabis derivative, as a Schedule 1 controlled substance under the Controlled Substances Act. The […]

  • http://thehealthequity.com/wp-content/uploads/2018/06/dea-cbd-696x366.jpg

    Federal Court Proves Gov’t Loyalty to Big Pharma, Rules CBD Has No Medical Value

    Washington, D.C. – The United States hemp industry was dealt a major blow on Monday after the federal U.S.  9th Circuit Court of Appeals upheld a decision by the Drug Enforcement Agency to list cannabidiol, commonly referred to as CBD, which is a non-psychoactive cannabis derivative, as a Schedule 1 controlled substance under the Controlled Substances Act. The […]

  • Newsletter

    Get the best viral stories straight into your inbox!

    Don't worry we don't spam

  • http://thehealthequity.com/wp-content/uploads/2018/06/brain-neuron-receptor.jpg

    Cannabidiol significantly reduces seizures in patients with severe form of epilepsy

    By NEW YORK UNIVERSITY SCHOOL OF MEDICINE Cannabidiol (CBD), a compound derived from the cannabis plant that does not produce a “high” and has been an increasing focus of medical research, was shown in a new large-scale, randomized, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy […]